Updates
-
-
Vumerity’s $88,000 List Price Not What ‘We Had Hoped,’ National MS Society Says
The National Multiple Sclerosis Society has criticized Biogen for the $88,000 yearly list price it placed on Vumerity (diroximel fumarate), the newly approved oral disease-modifying treatment (DMT) ... Read more -
7T MRI Reveals New Insights into Some RRMS Features
With the help of 7 Tesla magnetic resonance imaging (MRI), investigators discovered that leptomeningeal enhancement — a radiographic finding indicative of brain inflammation — ... Read more -
Single Dose of CD45-ADC Resets the Immune System, Delays the Onset of MS in Mice
A single dose of CD45-ADC, an investigational targeted therapy being developed to treat different types of autoimmune diseases, is enough to reset the normal ... Read more -
Sativex, Cannabis Extract for MS Spasticity, Now Available to Select Patients in England
The cannabis sativa plant extract Sativex is a cost-effective therapy for spasticity in multiple sclerosis (MS) and can be offered to patients in England ... Read more
-
What can changes in grey matter mean for MS? (Sponsored Post)
The brain is made up of two types of tissue: grey matter and white ... -
Long-term IFN-Beta Treatment Normalizes Immune Balance in RRMS, Study Shows
Long-term treatment with interferon beta (IFN-beta) corrects the defective immune balance characteristic of people ... -
Acthar Gel Quite Effective at Resolving Relapses as Alternative to Corticosteroids, Study Reports
Acthar Gel is more effective for treating flares in multiple sclerosis than other alternatives, including intravenous ... -
MS News that Caught My Eye Last Week: EU Lemtrada Safety Guidance, Targeted Treatment Project, SPMS Patients Unaware of Diagnosis
EMA Safety Group Advises Lemtrada Be Limited to ‘Highly Active’ RRMS Patients at Hospitals ... -
Early Damage on Brain Scans and Greater 5-Year Disability Help Predict 30-Year Outcomes in MS, Study Finds
A 30-year study of outcomes in multiple sclerosis (MS) patients reports that radiological findings ... -
Low Neurite Density in Spinal Cord Linked to Greater Physical Disability in RRMS Patients
People with relapsing-remitting multiple sclerosis (RRMS) have poorer neurite density — a measure that ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more